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The pregnant women and her unborn child who are human immunodeficiency virus (HIV) reactive are mostly innocent bearers of the brunt of the infection. Mother-to-
child transmission of HIV is a major route of new infections in 
children [1-3]. India has the third largest HIV epidemic in the world. 
The use of anti-retroviral therapy (ART) to mother-baby pairs has 
shown to be quite effective in the preventing the transmission of 
virus from mother-to-child [1,3,4]. The early diagnosis of children 
born to HIV-positive mother using HIV DNA-polymerase chain 
reaction (PCR) and treating children who are diagnosed HIV-
positive with anti-retroviral (ARV) drugs within their first 12 weeks 
of life reduces the mortality by 75% [2,3].
This retrospective study was conducted to analyze the 
incidence of HIV transmission in children born to HIV-infected 
pregnant women, the effect of maternal highly active ART, various 
maternal comorbidities, on ultimate outcome of the children.
METHODS
This retrospective study was done on mothers with HIV-positive 
serology and their infants. The analysis of the records of HIV-
positive mothers up to their delivery and follow-up records of 
their babies for 18 months of age was done who were admitted in 
M. Y. Group of Hospitals, Indore from January 2011 to December 
2013. Data were collected from PPTCT center in the Department 
of Obstetrics and Gynecology, Labor room records, Nursery 
records, and ART center. All HIV-positive pregnant women, who 
attended antenatal clinic and delivered at M.Y. Hospital and where 
complete records were available, were included in the study. HIV-
positive mothers who were delivered outside or did not receive 
single dose nevirapine or those with incomplete records were 
excluded from the study.
For screening of antenatal care patients, ELISA was used. For 
the children, HIV-DNA was used for the diagnosis at 6 weeks 
and at 6 months follow-up. The HIV-DNA test was done by 
sending the dried blood smear on the blot paper and it was sent 
to the reference laboratory Kasturbha Hospital in Mumbai. In 
the case of positive result, the whole blood sample was sent for 
confirmation. At 18 months of age, antibody testing was done. 
A statistical analysis was performed using Chi-square test, and 
Z-test to test the significance (p value) between the two groups.
RESULTS
During the study period, 173 cases of HIV positive pregnant 
women were registered, out of which 161 gave birth to 164 
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babies (including 1 triplet and 1 twin) as shown in Fig. 1. Out 
of the 164 babies delivered, 6 babies were still born, 2 died 
within 7 days, and another 6 died during the neonatal period. 
The perinatal mortality rate (PMR) was 48.78/1000 live births, 
and neonatal mortality rate (NMR) was 54.87/1000 live births. 
Both were significantly higher than the mortality rate in children 
born to seronegative mother during the same period which was 
25/1000 live births.
In this study, maximum women were belonging to age group 
<25 years; however, age of the mother did not affect the HIV 
transmission rates (p=0.851). Most of the mothers were of 
younger age in which 41 (25%) were primigravida, 73 (44.51%) 
second gravida. Most of the antenatal women were housewife 
40 (70%) and husbands of 93 (56.70%) women were unskilled 
workers, 26 (15.85%) drivers, and 16 (9.75%) were on other 
jobs. The occupation of father did not affect the mother-to-child 
transmission, as the majority of HIV-negative infants were born 
to same father’s occupation (p=0.350).
The normal labor (60%) was the most common mode of 
delivery and lower segment caesarean section (40%) was done 
only for obstetrics indication as per the current guidelines. The 
rate of transmission was not significantly affected by the mode 
of delivery (p=0.0787). The incidence of preterm (<37 weeks) 
deliveries was maximum (52%). The maximum transmission of 
HIV occurs in the third trimester, and the rate of transmission 
of HIV was more in term babies (70%) as compared to preterm 
babies (30%).
Only 55 (34.16%) HIV-positive mothers were eligible for 
treatment as they had low CD4 counts or other comorbidities 
such as tuberculosis in 8 and hepatitis B infection in one mother. 
The treatment was started but was not effective in preventing 
HIV transmission as 60% were HIV-positive against 30% babies 
where mothers did not receive any treatment. The difference was 
statistically significant with (p=0.032). The CD4 counts were less 
than 500 in 70% (7 out of 10) mothers with HIV positive babies 
and 47.2% (60 out of 151) mothers with HIV-negative babies 
(p=0.040).
The birth weight was below 2500 g in 40% HIV-positive 
babies and 47.67% of the HIV-negative babies (p=0.780). There 
were 42 admissions to the nursery of which 36 were discharged 
with mother. NICU admission was required in 40% of seropositive 
and 27.27% of seronegative babies (p=0.385). Prematurity and 
low birth weight (LBW) was the most common indications for 
admission in both the groups, followed by septicemia, NNHB 
and birth asphyxia. 14 children died during neonatal period and 
the most common cause of deaths was prematurity followed by 
septicemia.
Out of 164 babies, 17 children were lost to follow-up (16.95%) 
and 9 died during follow-up; however, none was admitted at 
MYH. The diagnoses of only 4 babies were known and out of 
them, 2 died of respiratory complaints, and 2 due to failure to 
thrive and diarrhea. HIV status of expired babies was not known; 
although, PPTCT center tried to call the phone numbers provided 
but other information was not available. Out of the 10 HIV-
positive babies, 5 babies were started on ART irrespective of their 
CD4 counts. Two babies were lost to follow-up, 2 died before 
ART was started and parents of one child refused treatment as 
the mother was terminally ill and father had abandoned them. 
A cause of death was malnutrition and diarrhea in one child, and 
in another child, it was not known.
DISCUSSION
The overall parent to child transmission rate in our study was 
8.06% with single dose nevirapine alone. This transmission rate 
was less than the expected 10-20% in a pilot project study done 
by NACO [1]. However, it is similar to a study from Chennai 
with MCT rate of 8.3% from a sample of 218 DNA-PCR and 
double from a study from Southern India which showed a 
transmission rate of 4% [5,6]. Others have shown even high 
transmission rates [7,8]. The maximum number of cases detected 
was young women, thus, emphasizing the growing pandemic and 
its propensity to involve young age group. Mandatory screening 
of HIV in school and colleges would be next seen if adequate 
prevention of HIV is not possible.
In our study, only 55% of pregnant women were eligible for 
ARV drugs for low CD4 counts and co-morbidities, but the HIV 
transmission rate was 60% in them compared to 30% babies who 
did not received any treatment which was statistically significant. 
The main reason of ineffectiveness of treatment in preventing 
transmission may be delayed commencement of treatment and 
presence of various comorbities like tuberculosis. Marinda 
Figure 1: Study population
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et al. [9] showed that HIV-positive mothers with high viral load 
are likely to transmit infection more to their infants. Other studies 
and also recent guidelines by WHO and NACO had shown that 
timely initiation of triple ARVs is helpful in suppression of viral 
load and thus preventing MCT [10-12].
The CD4 counts was <500/mm3 in 70% mothers with HIV-
positive babies compared to 47.2% mothers with HIV-negative 
babies, which was comparable to a study done by Marazzi 
et al. [13], which showed transmission rate of 50% with 
pregnant women without therapy. Some associated maternal 
risk factors together with low CD4 counts are anemia, advanced 
maternal disease, mastitis and acute maternal seroconversion 
during pregnancy and breastfeeding. Our study showed that the 
maximum transmission of HIV occurs in the third trimester, the 
rate of HIV transmission was about 70% as compared with 30% 
in preterm babies.
Although exclusive breastfeeding was advised as per the recent 
recommendations, mothers in both groups practiced top feeding 
and mixed feeding. Faulty feeding practices were responsible 
for 30% of transmission in HIV-positive group as babies turn 
positive after 6 months of age. However, this difference was not 
statistically significant as faulty feeding practices were seen in 
both the groups [14].
The cause of mother-to-child transmission was low immunity 
status of mother, time of ARVs initiation, and mixed feeding 
practices. These all parameters of transmission have been taken 
into care by NACO PPCT recent guidelines which say ART should 
be given to all HIV-positive pregnant women irrespective of their 
CD4 counts. For babies born to HIV-positive mother, exclusive 
breastfeeding should be continued for 6 months along with daily 
nevirapine, and after that breastfeeding should be continued 
with proper complimentary feeding until 1 year of age followed 
by slow cessation of breastfeeding. Hope this recent trend will 
benefit both mother and their babies for better survival and also 
HIV free life to the babies.
The incidence of high PMR and NMR in our study was because 
of the high incidence of intrauterine growth restriction, LBW 
babies, which may be due to low immune status of mother which 
makes them more prone to infection and other complications. 
However, the actual underlying cause remains undetermined. 
Growth failure was also seen in children born to HIV-positive 
mothers; however, we could not label HIV as the cause of growth 
failure because of other confounding factors like faulty feeding 
practices, and improper weaning which were prevalent in this 
population.
Limitations of the study were high incidence of lost to 
follow-up, which was due to lack of knowledge, parental 
ignorance, social stigma related to their HIV status leading to 
poor follow-up data not only during infancy but also during their 
further monthly ART center visits.
CONCLUSION
The risk of vertical transmission of HIV from mother-to-baby 
was 8%. Maternal HIV transmission is the primary means by 
which infants become infected. Hence, the prevention of maternal 
HIV transmission is of paramount importance.
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